MOESM2 of Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition
2016-04-14T05:00:00Z (GMT) by
Additional file 2: Fig S2. Indicated immune cell subsets were cultured in increasing concentrations of vemurafenib and cell viability was determined after 24Â h by FACS analysis. Shown is the mean (+SEM) of three independent experiments.